新しいバイオマーカーは,心不全と保存された対減少した射出分子を区別します
Camilla Hage1,2, Annika Mang3, Jean Claude Daubert4
1Karolinska Institutet, Department of Medicine, Cardiology unit, Stockholm, Sweden.
ESC heart failure
|February 19, 2026
まとめ
MYBPC3やFGF23のような新しいバイオマーカーは,保存されたエジェクション分数 (HFpEF) と減少したエジェクション分数 (HFrEF) の心不全を区別する. これらのマーカーは,心不全の患者の結果も予測します.
科学分野:
- 心臓病学 心臓病学
- バイオマーカーの発見
- 心不全 病理生理学 心不全 病理生理学
背景:
- 心不全 (HF) は,保存されたエジェクション分数 (HFpEF) と減少したエジェクション分数 (HFrEF) を有するHFと,潜在的に明確な根本的な原因を持つHFとして提示されます.
- これらの違いを理解することは,標的型療法にとって極めて重要です.
研究 の 目的:
- HFpEFとHFrEFの患者における新しい血バイオマーカーを探求する.
- バイオマーカーと臨床的特徴の関連性を評価する.
- HFpEFとHFrEFを区別し,患者のアウトカムを予測するバイオマーカーの能力を決定する.
主な方法:
- 7つの新しいアッセイ (ANGPT2,BMP10,DKK3,FABP3,FGF23,IGFBP7,MYBPC3) を含む19のプラズマバイオマーカーが,HFpEF (n=76) およびHFrEF (n=36) の患者で測定されました.
- バイオマーカーのレベルは,臨床データ,LVEFカテゴリー,および有害事象 (あらゆる原因による死亡,HF入院,LVAD,または心臓移植) と相関していました.
主要な成果:
- 7つの新しいバイオマーカー (FABP3を除く) は,HFrEFで一般的に高く,より悪いNYHAクラスと低いeGFRと関連していました.
- MYBPC3とFGF23は,HFrEFとHFpEFの間の最も優れた差別を示しました.
- HFpEFでは,ANGPT2は心室および心房機能の障害と相関し,IGFBP7およびMYBPC3は下痢機能障害と相関した.
- DKK3を除くすべてのバイオマーカーは有害な結果と関連しており,ANGPT2とIGFBP7はHFpEFでより強い関連性を示し,MYBPC3はHFrEFでより強い関連性を示した.
結論:
- より高いMYBPC3とFGF23レベルは,HFrEFとHFpEFを区別し,HFrEFにおける心筋細胞損傷とHFpEFにおける内皮機能障害/酸化ストレスを示唆する.
- MYBPC3はHFrEFにおいて非常に予後的であったが,ANGPT2とIGFBP7はHFpEFにおいて予後的であった.
- これらの発見は,HFrEF (心筋細胞損傷) とHFpEF (全身性炎症,酸化ストレス) の明確な病理生理学的要因を支持する.
関連する概念動画
01:17Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
625
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625
01:30Heart Failure IV: Classification and Diagnostic Evaluation
456
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
456
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
959
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
959
01:30Heart Failure V: Medical Management
388
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
388